IL6 and colitis: Paradoxically, NF-κB signaling in CAFs has dual regulatory roles: IKKβ activation suppresses hepatocyte growth factor (HGF)-mediated intestinal tumorigenesis via SMAD7 and SMURF1 induction [351] but promotes colitis-associated cancer through IL-6 overproduction [352].